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Abstract
Background
Several factors influence the outcomes in acute kidney injury (AKI), especially in intensive
care unit (ICU) patients. In this scenario, continuous renal replacement therapies (CRRT)
are used to control metabolic derangements and blood volume. Knowing this fact, it may
be possible to change the course of the disease and decrease the high mortality rate
observed. Thus, we aimed to evaluate the main risk factors for death in AKI patients need-
ing CRRT.
Results
This was a prospective, observational cohort study of ICU patients (N = 183) with AKI who
underwent continuous venovenous hemodiafiltration (CVVHDF) as their initial dialysis
modality choice. The patients were predominantly male (62.8%) and their median age was
65 (55–76) years. The most frequent comorbidities were cardiovascular disease (39.3%),
hypertension (32.8%), diabetes (24%), and cirrhosis (20.7%). The main cause of AKI was
sepsis (52.5%). At beginning of CVVHDF, 152 patients (83%) were using vasopressors.
The median SAPS 3 and SOFA score at ICU admission was 61 (50–74) and 10 (7–12),
respectively. The dialysis dose delivered was 33.2 (28.9–38.7) ml/kg/h. The median time
between ICU admission and CVVHDF initiation was 2 (1–4) days. The median cumulative
fluid balance during the CVVHDF period was -1838 (-5735 +2993) ml. The mortality rate up
to90 days was 58%. The independent mortality risk factors in propensity score model were:
chronic obstructive pulmonary disease (OR = 3.44[1.14–10.4; p = 0.028]), hematologic
malignancy (OR = 5.14[1.66–15.95; p = 0.005]), oliguria (OR = 2.36[1.15–4.9; p = 0.02]),
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positive daily fluid balance during CVVHDF (OR = 4.55[2.75–13.1; p<0.001]), and total
SOFA score on first dialysis day (OR = 1.27[1.12–1.45; p<0.001]).
Conclusions
Dialysis-related factors may influence the outcomes. In our cohort, positive daily fluid bal-
ance during CRRT was associated with lower survival. Multicenter, randomized studies are
needed to assess fluid balance as a primary outcome to define the best strategy in this
patient population.
Introduction
Acute kidney injury (AKI) is common in patients admitted to intensive care unit (ICU) and is
associated with the dysfunction of multiple organs and systems (DMOS) [1]. These patients
are generally older people [2, 3], presenting with multiple comorbidities and some degree of
renal dysfunction prior to hospitalization, and have often undergone invasive procedures [4].
The main cause of AKI is sepsis, which accounts for approximately half of the cases [4–6].
A significant number of these patients require dialysis during disease development. Within
this setting, in which patients present with hemodynamic instability, are on mechanical venti-
lation, and are hypercatabolic and oliguric, continuous renal replacement therapies (CRRT)
are often used [4].
In such cases, several factors influence the outcome. Some of these variables are related to
the intrinsic conditions of the patient, such as age, comorbidities, severity of the disease that
caused the AKI, metabolic disorders [4, 7], organ dysfunctions, and weight gain during the
resuscitation phase [8, 9]. Other factors that seem to influence the prognosis of these patients
are those associated with the therapy itself, such as the type of dialysis modality [10], the time
when the procedure was initiated [5], the delivered dose of dialysis, metabolic control and vol-
ume status obtained during the course of treatment [11].
Fluid resuscitation is considered a cornerstone therapy for critically ill patients at risk for or
with AKI [12], especially with the purpose to maintain adequate renal perfusion, to treat hypo-
volemia, and to improve cardiac output [13,14]. Recently, the concept that liberal fluid adminis-
tration brings positive consequences for the kidney has been challenged. Several observational
studies have linked positive fluid balance with AKI occurrence and mortality, especially before
RRT initiation [8, 14–16]. However, only a small number of studies have evaluated the associa-
tion between fluid overload and mortality during renal replacement therapy [11,15,17, 18].
Our aim was to assess the factors related to death in a cohort of patients admitted to the
ICU with AKI in need of dialysis, who underwent continuous venovenous hemodiafiltration
(CVVHDF) in a private and a tertiary hospital.
Materials and methods
Type of study
A prospective, observational study.
Study setting
The study was conducted in the adult ICU of the Hospital Israelita Albert Einstein (HIAE), in
Sao Paulo (SP), Brazil. The recruitment period was from January 20, 2013 to April 30, 2014.
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Population
Inclusion criteria. The study included ICU patients with AKI, who had been initially
referred for CVVHDF by the nephrology medical team.
Exclusion criteria. Patients who refused to participate in the study.
Patients diagnosed with end-stage renal disease (ESRD) and already undergoing regular
dialysis program.
Patients who did not complete 24 hours of therapy.
Parameters analyzed
The following baseline characteristics were assessed: age, gender, race, comorbidities, such as
diabetes mellitus (DM), hypertension, cardiovascular disease (CVD), chronic obstructive pul-
monary disease (COPD), cirrhosis, neurological diseases, rheumatic diseases, solid tumors,
hematologic malignancies, bone marrow transplantation (BMT), acquired immunodeficiency
syndrome (AIDS), and solid organ transplant.
The study also assessed the reasons for ICU admission, the type of patient (medical or surgi-
cal), and the main causes of AKI.
The SAPS 3 score (Simplified Acute Physiology Score 3) was used as an indicator of severity
and prognosis while the patient was in the ICU. The SOFA score (Sequential Organ Failure
Assessment) was used to determine organ dysfunctions and was assessed on admission to the
ICU and on the first (D1), third (D3), and seventh (D7) days of CVVHDF.
On initiating CVVHDF, we assessed the use of vasopressors and/or inotropic agents,
mechanical ventilation, sedation, and enteral and parenteral nutrition, as well as the presence
of oliguria (diuresis <400 ml/24 hours in the first CVVHDF day).
Changes in body weight (%) were also analyzed during the period between hospital admis-
sion and CVVHDF initiation.
Baseline renal function and AKI stages
Baseline renal function was assessed through the lowest levels of plasma creatinine within a
3-month period before admission (when available), or levels at hospital admission. The corre-
sponding glomerular filtration rate (GFR) was estimated through the formula of the Modifica-
tion of Diet in Renal Disease (MDRD) study.
On initiation of dialysis, the AKI was classified according to the KDIGO (Kidney Disease:
Improving Global Outcomes) guidelines. Briefly, the AKI is classified as stage 1 when there is
an absolute increase of 0.3 mg/dl in creatinine levels or an increase greater or equal to 150 to
200% of the creatinine level or a urinary flow lower than 0.5 ml/kg/h for more than 6 hours.
Stage 2 is reached when creatinine levels are greater than 200 to 300% or the urinary flow is
lower than 0.5 ml/kg/h for a period of more than 12 hours. Stage 3 is reached when creatinine
levels increase to over 300% or higher than 4.0 mg/dl, with an increase of at least 0.5 mg/dl, a
urinary flow lower than 0.3 ml/kg/h for 24 hours, or anuria for 12 hours.
Dialysis data
The following CVVHDF data were investigated: the time lapse between ICU admission and
initiating dialysis, the dialysis dose (in ml/kg/h of effluent), the duration (in days) of treatment,
fluid balance (FB) (in L) during CVVHDF period, and daily fluid balance (L). The FB was cal-
culated from the difference between losses (diuresis, drains, loss by dialysis) and gains (nutri-
tion, fluids, vasopressors, and other medicines). The delivered dose of dialysis was calculated
daily by multiplying the volume of effluent by the ratio of the urea effluent and serum urea.
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Outcomes
Mortality rates were assessed for up to 90 days after initiating CVVHDF. For surviving
patients, dialysis dependence was assessed at the time of hospital discharge, and renal function
(in those who had recovered it) was determined by measuring creatinine levels and the esti-
mated glomerular filtration rate (eGFR).
Treatment protocol
The protocol was based on the one performed in a previous study [19]. Briefly, CVVHDF was
performed with a Prismaflex machine (Gambro Renal Products, France), with an M100 hemo-
filter and an AN69 membrane (Gambro Renal Products, France).
Vascular access was obtained by inserting an 11.5 F triple-lumen venous catheter (Arrow
International, PA, USA) into the internal jugular vein (preferably on the right side), or into the
femoral vein, guided by ultrasound. Blood flow was maintained constant at 100 ml/minute.
Regional citrate anticoagulation was applied with a 4% trisodium citrate solution and cal-
cium replacement solution (0.75% CaCl2) were infused into the arterial line (through the
three-way tap) and into the third line of the dialysis catheter, respectively. The infusion of
citrate solution was adjusted by the nursing staff according to a spreadsheet to maintain the
concentration of post-filter ionic calcium within a range of between 0.25 and 0.30 mmol/L.
Similarly, the calcium solution infusion was adjusted to maintain the systemic concentration
of ionic calcium within a range of between 1.12 and 1.20 mmol/L.
The prescribed dialysis dose was 35 ml/kg/h (total volume of effluent).
The hemofilter and the extracorporeal circuit were replaced every 72 hours.
Ethics approval and consent to participate
Patients or the responsible caregiver received and signed the informed consent forms. The
project was approved by the Local Ethics Committee (Hospital Israelita Albert Einstein),
under number 1627–12.
Statistical analysis
The qualitative variables were described in absolute frequencies and percentages, and the
quantitative variables were described in means and standard deviations or medians and inter-
quartile ranges (IQR), depending on the distribution of normality. The distribution of numeri-
cal variables was investigated through histograms and the Shapiro-Wilk test of normality. The
survival function within 90 days was estimated by the Kaplan-Meier method.
The association between categorical variables was evaluated by Pearson’s chi-squared test
or Fisher’s exact test. Comparisons between numerical variables were performed by t-test or
Mann-Whitney’s test, depending on normality.
An analysis of factors associated with death was performed through simple and multiple
forward logistic regression models. Variables with a p-value less than or equal to 0.15 in the
simple approach were included in a multivariate model, in which the variables were selected
step-by-step. After selecting the variables, only the final obtained multiple models was pre-
sented. The results of models were presented in estimated odds ratios and 95% confidence
intervals as well as the p-values. An additional Kaplan Meier survival analysis was performed
within 90 days of CVVHDF initiation with each variable related with mortality and compari-
sons were made using the Log Rank method.
We performed additional statistical analysis including Cox proportional hazard model and
a propensity score analysis to adjust for confounds. The propensity score was estimated by
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using a multivariate logistic regression of patients receiving positive mean daily fluid balance
or not. Thus, the propensity score analysis was maintained as final model. The Cox regression
analysis was included as supplementary file.
Analyses were performed using the R package (R Core Team, 2013. R: A language and envi-
ronment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL
http://www.R-project.org/). The significance level was 5%.
Results
Description of the demographic and clinical characteristics of patients
A total of 207 patients were assessed, of whom 7 were excluded because they did not complete
twenty four hours of therapy, and 17 were excluded because they had ESRD and were on a reg-
ular dialysis program. The main clinical and demographic features are presented in Table 1. Of
the 183 patients who constituted our sample, 115 (62.8%) were male and 162 (88.5%) were
white. The median age was 65 (55–76) years. The most common reason for ICU admission
was infection, accounting for 101 (57.0%) patients, and 132 (72.1%) were medical patients.
The most common comorbidity was cardiovascular disease (n = 72; 39.3%), followed by hyper-
tension (n = 60; 32.8%) and diabetes mellitus (n = 44; 24%). Sepsis was the most common
cause of AKI (52.5%).
On CVVHDF initiation, 152 patients (83%) were using vasoactive drugs, and 145 patients
(79.2%) were on mechanical ventilation. The median SAPS 3 score at ICU admission was 61 (50–
74), with a predicted mortality of 37.7% (20,1–64%). The SOFA score at ICU admission was 10
(7–12). The periods spent in hospital and in the ICU were 35 (21–67) and 14 (7–22), respectively.
The main data related to continuous dialysis, comparing survivors and non-survivors are
presented in Table 2. The delivered dialysis dose was 33.2 ml/kg/h. The median time of
CVVHDF was 6 days (3–10). The median time between hospital admission and CVVHDF
initiation was 2 days (1–4), with no statistically significant difference between groups. The
median time between ICU admission and CVVHDF initiation was 2 days (1–4). The median
cumulative fluid balance during the CVVHDF period was -1838 ml (-5735 +2993). There
median of interruption time during CVVHDF was 2 (0–10) hours. The number of patients
who shifted from CVVHDF to intermittent dialysis was 68 (87,2%) in survivors group and 31
(29,5%) in non-survivors.
Survival up to 90 days and factors related to death
The mortality rate observed during a 90-day period was 57.4% (n = 105).
Table 3 demonstrates the significant variables in the simple and multiple logistic regression
analyses, using propensity score matching for positive daily fluid balance (yes or no). Kaplan
Meier curve survival is described in S1 Fig. Cox regression analysis was also performed and it
is described in S1 Table.
Renal function at hospital discharge
Among the patients who survived (78) and those who recovered renal function (55 patients,
70.5% of survivors), the median baseline eGFR was 81 mL/min. (IQR: 47–115), higher than
that observed in the group of dialysis-dependent patients at discharge (23 patients, 29.5% of
survivors), in which the median was 38 mL/min (18 to 70), p = 0.002.
In those who recovered renal function, there was a reduction in eGFR at hospital discharge,
to 50 ml/min (30–66) (p<0.001), and the median creatinine level was 1.4 mg/dl (1.0 to 1.9),
when compared to the baseline.
Negative fluid balance during continuous hemodiafiltration in acute kidney injury patients
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Table 1. Description of the main clinical and demographic data.
Variables Number of cases (n = 183)
Gender
Male 115 (62.8%)
Race
Caucasian 162 (88.5%)
Age (years) 65 (55–76)
Patient classification
Medical 132 (72.1%)
Surgical 51 (27.9%)
Reason for ICU admission
Infection 101 (57.0%)
Cardiac failure 12 (6.5%)
Liver failure 12 (6.5%)
Hypovolemic/bleeding shock 2 (1.1%)
Other medical causes 5 (2.7%)
Solid organ transplantation 20 (10.9%)
(Liver transplantation) 15 (8.2%)
Elective or emergency surgery 31 (16.0%)
Comorbidities
Diabetes mellitus 44 (24.0%)
Hypertension 60 (32.8%)
Cardiovascular disease 72 (39.3%)
Chronic obstructive pulmonary disease and other pulmonary diseases 23 (12.6%)
Solid organ neoplasia 28 (15.3%)
Hematologic malignancy or BMT 36 (19.6%)
Cirrhosis 38 (20.7%)
Liver transplantation 33 (18.0%)
Causes of AKI
Sepsis 96 (52.5%)
Cardio renal syndrome 15 (8.2%)
Hepatorenal syndrome 16 (8.7%)
Solid organ transplantation 20 (10.9%)
Trauma and surgery 21 (11.5%)
Other causes 15 (8.2%)
Classification of AKI at beginning of CVVHDF
KDIGO 3 120 (65.6%)
KDIGO 2 54 (29.5%)
KDIGO 1 9 (4.9%)
Baseline creatinine in mg/dL 1.00 (0.70–1.51)
Baseline eGFR in mL/min/1.73 m2 72 (40–102)
Vasopressors at beginning of CVVHDF 152 (83.0%)
Mechanical ventilation at beginning of CVVHDF 145 (79.2%)
Sedation at beginning of CVVHDF 136 (74.3%)
Accompanying oliguria at beginning of CVVHDF 114 (62.3%)
SAPS 3 score at ICU admission 61 (50–74)
Predicted mortality by SAPS 3 (%) 37.7 (20.1–64.0)
SOFA score at ICU admission 10 (7–12)
Total SOFA score on the first day of CVVHDF (n = 183) 13 (11–16)
(Continued )
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SOFA score
Regarding the SOFA scores, there were increased admission levels for day 1, and these
remained higher than those on days 3 and 7, both for patients who died and for survivors
(Table 4). However, when comparing the cardiovascular and respiratory SOFA components
with fatal outcome, a statistically significant relationship was encountered, i.e., those who had
died presented higher levels than the survivors on the first, third, and seventh days (Table 5).
Discussion
In this prospective observational study, critically ill patients with AKI, treated with CVVHDF,
a positive fluid balance during dialysis was associated with shorter survival during the first 90
days.
Fluid overload causes stress to the cardiovascular system, edema in many tissues, and is
associated with organ dysfunction and increased mortality rates [20–23]. Data suggest that the
accumulation of fluid contributes to onset of AKI and seems to delay recovery time [24–26].
Venous congestion, increased intra-abdominal pressure, and increased renal interstitial pres-
sure are possible pathophysiological mechanisms involved in the genesis and perpetuation of
kidney damage [27,28].
Table 1. (Continued)
Variables Number of cases (n = 183)
Total SOFA score on the third day of CVVHDF (n = 173) 13 (11–15)
Total SOFA score on the seventh day of CVVHDF (n = 98) 14 (11–16)
Length of stay in hospital (days) 35 (21–67)
Length of stay in ICU (days) 14 (7–22)
Mortality up to 90 days 105 (57.4%)
ICU, intensive care unit; BMT, bone marrow transplantation; AKI, acute kidney injury; CVVHDF, continuous
venovenous hemodiafiltration; eGFR, estimated glomerular filtration rate; KDIGO, Kidney Disease
Improving Global Outcomes classification of acute kidney injury; SAPS 3, Simplified Acute Physiology Score
3; SOFA, Sequential Organ Failure Assessment score. Categorical variables described by absolute value
(percentage) and numeric variables described by median (IQR).
https://doi.org/10.1371/journal.pone.0175897.t001
Table 2. Comparison of the aspects related to continuous dialysis between survivors and non-survivors.
Variables Survivors (78) Non-survivors (105) Total (183) P value
Dialysis prescribed dose (mL/kg/h) 37.6 (33–45.1) 38 (33.7–43.2) 37.9 (33.4–43.9) 0.86
Dialysis delivered dose (mL/kg/h) 32.8 (28.8–40) 33.6 (29.3–38.5) 33.2 (28.9–38.7) 0.88
Interruption time during CVVHDF (hours) 1 (0–8.6) 2 (0–15.8) 2 (0–10) 0,21
Number of days on CVVHDF 5 (3–8) 7 (3–12) 6 (3–10) 0.45
Time from ICU admission to starting time of CVVHDF (days) 1 (1–3) 2 (1–4) 2 (1–4) 0,01
Percentage change of weight from hospital admission to beginning of CVVHDF
(%)
5.62 (0.82–12.13) 8.11 (0.95–17.97) 7.1 (1.0–15.4) 0.15
Fluid balance (cumulative) during dialysis (L) -4.13 (-7.78–-
0.77)
+0.65 (-3.68–+5.23) -1.84 (-5.74–
+ 2.99)
<0,001
Daily fluid balance during dialysis (L) -0.74 (-1.28–-
0.17)
-0.08 (-0.7–+1.0) -0.35 (-1.08–+0.43) <0,001
CVVHDF, continuous venovenous hemodiafiltration; ICU, intensive care unit. Categorical variables described by absolute value (percentage) and numeric
variables described by median (IQR).
https://doi.org/10.1371/journal.pone.0175897.t002
Negative fluid balance during continuous hemodiafiltration in acute kidney injury patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0175897 April 20, 2017 7 / 13
Weight gain was observed in patients between hospital admission and the initiation of dial-
ysis. Although some studies have showed that fluid overload, especially because volume resus-
citation, is associated with higher mortality rates [29], the present data demonstrated that
there was an increased risk of death in patients who were unable to achieve negative fluid bal-
ance during the period in which they were undergoing CRRT. According to our findings, in a
cohort of 492 patients, Silversides et al. demonstrated that the most positive fluid balance after
initiating RRT was associated with lower survival rates [11]. Analyzing data from the RENAL
study with 1,453 patients, Bellomo et al. demonstrated that a negative fluid balance during
RRT was associated with a lower risk of death as well as more free time for dialysis and shorter
hospital and ICU stay [30].
It is a matter of debate whether the association between positive fluid balance and higher
mortality rates is a result from a causal effect per se or only represents a disease severity marker
[31]. By assessing the SOFA score, we observed that organ dysfunctions intensified during the
period between ICU admission and the first week of dialysis. When specifically assessing the
Table 3. Multivariate logistic regression with death at 90 days.
Univariate analysis Multivariate analysis
Odds ratio (CI 95%) p-value Odds ratio (CI 95%) p-value
Positive daily fluid balancea (yes vs no) 4.37 (2.15–8.88) <0.001 4.55 (2.75–13.1) <0.001
Infection 1.97 (1.09–3.60) 0.025
COPD 2.32 (0.91–6.70) 0.093 3.44 (1.14–10.4) 0.028
Hematologic malignancy 2.82 (1.13–8.06) 0.035 5.14 (1.66–15.95) 0.005
Hepatic cirrhosis 2.47 (1.15–5.69) 0.025 2.39 (0.99–5.78) 0.052
Liver transplantation 0.41 (0.19–0.88) 0.023
Vasopressors 2.12 (0.98–4.73) 0.060
Mechanical ventilation 2.89 (1.39–6.18) 0.005
Sedation 2.25 (1.15–4.46) 0.018
Oliguria 1.85 (1.26–2.71) 0.002 2.36 (1.15–4.90) 0.020
SAPS 3 score 1.03 (1.01–1.05) 0.002
Time from ICU admission to CVVHDF initiation (d) 1.07 (0.99–1.18) 0.093 1.10 (0.99–1.23) 0.063
SOFA 1.30 (1.15–1.46) <0.001 1.27 (1.12–1.45) <0.001
a Treatment-effects estimation by propensity-score matching
COPD, chronic obstructive pulmonary disease; CVVHDF, continuous venovenoushemodiafiltration; SAPS 3, Simplified Acute Physiology Score 3
https://doi.org/10.1371/journal.pone.0175897.t003
Table 4. Comparisons of SOFA values in relation to admission.
SOFA score Death
No Yes
Admission in ICU 10 (7–12) 10 (7–12)
Day 1 12 (10–14) 14 (12–16)
Day 3 11 (9–14) 15 (13–17)
Day 7 10 (8–14) 15 (12–17)
p (Admission x Day 1)* <0.001 <0.001
p (Admission x Day 3)* <0.001 <0.001
p (Admission x Day 7)* 0.039 <0.001
SOFA, Sequential Organ Failure Assessment score; ICU, intensive care unit.
*Mann-Whitney´s test for non-parametric variable
https://doi.org/10.1371/journal.pone.0175897.t004
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cardiovascular and respiratory SOFA components, it was observed that patients who died pre-
sented higher scores than those who survived during the first week of renal replacement ther-
apy. Hypothetically, a more favorable hemodynamic profile could have provided greater
volume withdrawal, thus decreasing pulmonary edema and improving the respiratory parame-
ters of survivors. But, in our study the association remained after adjustment for confoudings,
as SAPS3, SOFA score, and oliguria, suggesting that illness severity may not only account for
our findings.
Another important aspect in AKI treatment is the time when dialysis is initiated. Theoreti-
cally, early initiation of dialysis should decrease the complications of fluid overload and the
accumulation of uremic toxins. Moreover, it follows that patients who spontaneously recover
their renal functions could have received dialysis unnecessarily [32–34]. In our cohort, the
time between ICU admission and the onset of CVVHDF was not a risk factor for death.
Recently, two clinical trials addressed the important issue in the treatment of AKI. The first,
a single-center study, demonstrated that the group of patients in which dialysis was initiated
early (KDIGO stage 2) presented lower mortality rates after 90 days (39.3% vs. 54.7%) than the
group who started renal replacement therapy later (KDIGO stage 3) [35]. The other, which
was a multicenter study with a larger number of patients (n = 620), presented different results.
When comparing early and late RRT (KDIGO 3, and at least one of the following criteria:
hyperkalemia, metabolic acidosis, azotemia, pulmonary edema, or oliguria for more than 72
hours), there was no difference in mortality rates after 60 days (48.5% x 49.7%). Furthermore,
in the group undergoing late renal replacement therapy, nearly 50% of patients recovered
renal function and did not require dialysis [36]. The differences in the randomization criteria
(stages of AKI) may explain these opposite results. In our sample, most of the patients were
classified as KDIGO stage 3 and the AKI classification by this criterion was not associated with
mortality. Two other large trials are ongoing, and the results will help to establish the best time
to initiate renal replacement therapy in patients with AKI [37,38].
Until recently, it was believed that an intensive dose of dialysis affected the survival of pa-
tients with AKI in ICU. Ronco et al. reported that an effluent rate of 35–45 mL/kg/h increased
the survival of patients with AKI undergoing continuous venovenous hemofiltration (CVVH)
compared to a rate of 20 ml/kg/h [39]. Subsequently, two major studies, ATN and RENAL
[40,41], determined that an intensive dose of dialysis (35–40 ml/kg/h) did not reduce the mor-
tality of patients with AKI in the ICU and submitted to CVVHDF when compared to a dose of
20–25 ml/kg/h. In the present study, the effective effluent rate was around 30 ml/kg/h, which
Table 5. Comparison between cardiovascular and respiratory SOFA components on the first, third, and seventh days of dialysis and mortality.
Variables Death p-value*
No Yes
Cardiovascular SOFA (mean ± SD)
First day 2.8 ± 1.5 3.4 ± 1.1 0.005
Third day 2.0 ± 1.5 3.2 ± 1.2 < 0.001
Seventh day 1.7 ± 1.5 3.1 ± 1.4 < 0.001
Respiratory SOFA (mean ± SD)
First day 1.4 ± 1.0 1.9 ± 1.1 0.004
Third day 1.2 ± 0.9 1.6 ± 1.1 0.009
Seventh day 1.0 ± 0.9 1.4 ± 1.1 0.069
SOFA, Sequential Organ Failure Assessment score
* Student’s t-test for the comparison of means
https://doi.org/10.1371/journal.pone.0175897.t005
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could be enough to counteract any interruptions in the procedures for filter change, tests, and
surgical procedures.
Multivariate analysis revealed that oliguria was an independent risk factor for death. In
more recent systems for defining and classifying AKI, the urine volume was included both as
diagnostic criteria and for staging severity [42,43]. Some studies have also revealed that oli-
guria, regardless of creatinine levels, may be correlated with adverse outcomes, especially with
the long-term need for dialysis and mortality [44].
Some comorbidities encountered in our patient population, specifically liver cirrhosis,
hematologic malignancies, and COPD, were associated with a higher risk of death. Patients
with COPD are susceptible to AKI, especially during periods of pulmonary disease exacerba-
tion, and this association increases mortality. AKI is also a frequent complication and affects
up to 2/3 of patients with hematologic malignancies admitted to ICUs. The etiology of AKI is
multifactorial and is also an independent risk factor for death within this scenario [45–47].
Our study has several limitations. As this is an observational, single-center study, the popu-
lation is subject to selection bias. There was no specific protocol for the choice of dialysis
modality or for initiating RRT. Such decisions were left to the nephrology team, which, how-
ever, remained constant throughout the study period. There was also no protocol to define the
removal rate of fluids during dialysis, and the desired fluid balance was planned daily after dis-
cussion between nephrologists and the ICU team.
Conclusions
Dialysis-related factors may influence the outcomes in AKI. In our cohort, positive daily fluid
balance during the period in which the patients remained in CVVHDF was associated with
lower survival. Multicenter and randomized studies are needed to assess fluid balance as a pri-
mary outcome to define the best strategy in this patient population.
Supporting information
S1 Table. Cox regression univariate and multivariate analysis for 90-day mortality.
(DOCX)
S1 Fig. Kaplan-Meier survival curve for a 90-day period from CVVHDF initiation.
CVVHDF, continuous venovenous hemodiafiltration.
(TIF)
Acknowledgments
We thank Elivane da Silva Victor and Eleonora Maria de Jesus Oliveira for statistical analysis.
Author Contributions
Conceptualization: TOCS MASO MSD.
Data curation: TOCS MASO MSD.
Formal analysis: TOCS MASO MSD.
Funding acquisition: MSD.
Investigation: TOCS JCMM MCB VGPJ BFCS OFPS.
Methodology: MSD OFPS.
Negative fluid balance during continuous hemodiafiltration in acute kidney injury patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0175897 April 20, 2017 10 / 13
Project administration: MSD.
Resources: JCMM MCB VGPJ BFCS OFPS.
Supervision: MSD OFPS.
Validation: TOCS MSD.
Visualization: TOCS.
Writing – original draft: TOCS MASO MSD.
Writing – review & editing: TOCS MASO MSD JCMM MCB VGPJ BFCS OFPS.
References
1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S et al. Acute renal failure in critically
ill patients: a multinational, multicenter study. JAMA. 2005; 294: 813–8 https://doi.org/10.1001/jama.
294.7.813 PMID: 16106006
2. Hsu CY, McCulloch CE, Fan D, Ordoñez JD, Chertow GM, Go AS. Community-based incidence of
acute renal failure. Kidney Int. 2007; 72: 208–12 https://doi.org/10.1038/sj.ki.5002297 PMID: 17507907
3. Yilmaz R, Erdem Y. Acute kidney injury in the elderly population. Int Urol Nephrol. 2010; 42: 259–71.
https://doi.org/10.1007/s11255-009-9629-7 PMID: 19707882
4. Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN et al. Epidemiology of acute kidney
injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015; 41: 1411–23.
https://doi.org/10.1007/s00134-015-3934-7 PMID: 26162677
5. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M et al. Septic acute kidney injury
in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007; 2: 431–9.
https://doi.org/10.2215/CJN.03681106 PMID: 17699448
6. Alobaidi R, Basu RK, Goldstein SL, Bagshaw SM. Sepsis-Associated Acute Kidney Injury. Semin
Nephrol. 2015; 35: 2–11. https://doi.org/10.1016/j.semnephrol.2015.01.002 PMID: 25795495
7. Allegretti AS, Steele DJ, David-Kasdan JA, Bajwa E, Niles JL, Bhan I. Continuous renal replacement
therapy outcomes in acute kidney injury and end-stage renal disease: a cohort study. Crit Care. 2013;
17: R109. https://doi.org/10.1186/cc12780 PMID: 23782899
8. de Oliveira FS, Freitas FG, Ferreira EM, de Castro I, Bafi AT, de Azevedo LC et al. Positive fluid balance
as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock. J Crit
Care. 2015; 30: 97–101. https://doi.org/10.1016/j.jcrc.2014.09.002 PMID: 25269788
9. Teixeira C, Garzotto F, Piccinni P, Brienza N, Iannuzzi M, Gramaticopolo S et al. Fluid balance and
urine volume are independent predictors of mortality in acute kidney injury. Crit Care. 2013; 17: R14.
https://doi.org/10.1186/cc12484 PMID: 23347825
10. Schneider AG, Bellomo R, Bagshaw SM, Glassford NJ, Lo S, Jun M et al. Choice of renal replacement
therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-anal-
ysis. Intensive Care Med. 2013; 39: 987–97. https://doi.org/10.1007/s00134-013-2864-5 PMID:
23443311
11. Silversides JA, Pinto R, Kuint R, Wald R, Hladunewich MA, Lapinsky SE et al. Fluid balance, intradialy-
tic hypotension, and outcomes in critically ill patients undergoing renal replacement therapy: a cohort
study. Crit Care. 2014; 18: 624. https://doi.org/10.1186/s13054-014-0624-8 PMID: 25407408
12. Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney
injury. Nat Rev Nephrol. 2014; 10:37–47. https://doi.org/10.1038/nrneph.2013.232 PMID: 24217464
13. Kellum JA, Cerda J, Kaplan LJ, Nadim MK, Palevsky PM. Fluids for prevention and management of
acute kidney injury. Int J Artif Organs. 2008; 31:96–110. PMID: 18311727
14. Prowle JR, Chua HR, Bagshaw SM, Bellomo R. Clinical review: Volume of fluid resuscitation and the
incidence of acute kidney injury—a systematic review.Crit Care. 2012; 16:230. https://doi.org/10.1186/
cc11345 PMID: 22866958
15. Wang N, Jiang L, Zhu B, Wen Y, Xi XM. Fluid balance and mortality in critically ill patients with acute kid-
ney injury: a multicenter prospective epidemiological study. Crit Care. 2015; 19:371. https://doi.org/10.
1186/s13054-015-1085-4 PMID: 26494153
16. Salahuddin N, Sammani M, Hamdan A, Joseph M, Al-Nemary Y, Alquaiz R et al. Fluid overload is an
independent risk factor for acute kidney injury in critically Ill patients: results of a cohort study. BMC
Nephrol. 2017; 18:45. https://doi.org/10.1186/s12882-017-0460-6 PMID: 28143505
Negative fluid balance during continuous hemodiafiltration in acute kidney injury patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0175897 April 20, 2017 11 / 13
17. Neyra JA, Li X, Canepa-Escaro F, Adams-Huet B, Toto RD, Yee J et al. Cumulative Fluid Balance and
Mortality in Septic Patients With or Without Acute Kidney Injury and Chronic Kidney Disease. Crit Care
Med. 2016; 44:1891–900 https://doi.org/10.1097/CCM.0000000000001835 PMID: 27352125
18. Kim IY, Kim JH, Lee DW, Lee SB, Rhee H, Seong EY et al. Fluid overload and survival in critically ill
patients with acute kidney injury receiving continuous renal replacement therapy. PLoS One. 2017;
4;12:e0172137
19. Durão MS, Monte JC, Batista MC, Oliveira M, Iizuka IJ, Santos BF et al. The use of regional citrate
anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury. Crit Care Med.
2008; 36: 3024–9. https://doi.org/10.1097/CCM.0b013e31818b9100 PMID: 18824904
20. Stein A, de Souza LV, Belettini CR, Menegazzo WR, Vie´gas JR, Costa Pereira EM et al. Fluid overload
and changes in serum creatinine after cardiac surgery: predictors of mortality and longer intensive care
stay. A prospective cohort study. Crit Care. 2012; 16: R99. https://doi.org/10.1186/cc11368 PMID:
22651844
21. Sakr Y, Vincent JL, Reinhart K, Groeneveld J, Michalopoulos A, Sprung CL et al. Sepsis Occurence in
Acutely Ill Patients Investigators. High tidal volume and positive fluid balance are associated with worse
outcome in acute lung injury. Chest. 2005; 128: 3098–108. https://doi.org/10.1378/chest.128.5.3098
PMID: 16304249
22. Lobo SM, Ronchi LS, Oliveira NE, Brandão PG, Froes A, Cunrath GS et al. Restrictive strategy of
intraoperative fluid maintenance during optimization of oxygen delivery decreases major complications
after high-risk surgery. Crit Care. 2011; 15:R226. https://doi.org/10.1186/cc10466 PMID: 21943111
23. Nisanevich V, Felsenstein I, Almogy G, Weissman C, Einav S, Matot I. Effect of intraoperative fluid
management on outcome after intraabdominal surgery. Anesthesiology. 2005; 103: 25–32. PMID:
15983453
24. Wang N, Jiang L, Zhu B, Wen Y, Xi XM. Fluid balance and mortality in critically ill patients with acute kid-
ney injury: a multicenter prospective epidemiological study. Crit Care. 2015; 19: 371. https://doi.org/10.
1186/s13054-015-1085-4 PMID: 26494153
25. Zhang L, Chen Z, Diao Y, Yang Y, Fu P. Associations of fluid overload with mortality and kidney recov-
ery in patients with acute kidney injury: A systematic review and meta-analysis. J Crit Care. 2015; 30:
860.e7–13
26. Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP et al. Fluid accumulation,
survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;
76: 422–7. https://doi.org/10.1038/ki.2009.159 PMID: 19436332
27. Dalfino L, Tullo L, Donadio I, Malcangi V, Brienza N. Intra-abdominal hypertension and acute renal fail-
ure in critically ill patients. Intensive Care Med. 2008; 34: 707–13. https://doi.org/10.1007/s00134-007-
0969-4 PMID: 18157662
28. Wauters J, Claus P, Brosens N, McLaughlin M, Malbrain M, Wilmer A. Pathophysiology of renal hemo-
dynamics and renal cortical microcirculation in a porcine model of elevated intra-abdominal pressure. J
Trauma. 2009; 66: 713–9. https://doi.org/10.1097/TA.0b013e31817c5594 PMID: 19276743
29. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive
fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care
Med. 2011; 39: 259–65. https://doi.org/10.1097/CCM.0b013e3181feeb15 PMID: 20975548
30. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lee J et al. An observational study fluid balance and
patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Ther-
apy trial. Crit Care Med. 2012; 40: 1753–60. https://doi.org/10.1097/CCM.0b013e318246b9c6 PMID:
22610181
31. Bagshaw SM, Brophy PD, Cruz D, Ronco C. Fluid balance as a biomarker: impact of fluid overload on
outcome in critically ill patients with acute kidney injury. Crit Care 2008; 12: 169. https://doi.org/10.1186/
cc6948 PMID: 18671831
32. Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, Wald R et al. A comparison of early versus
late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic
review and meta-analysis. Crit Care. 2011; 15: R72. https://doi.org/10.1186/cc10061 PMID: 21352532
33. Oh HJ, Shin DH, Lee MJ, Koo HM, Doh FM, Kim HR et al. Early initiation of continuous renal replace-
ment therapy improves patient survival in severe progressive septic acute kidney injury. J Crit Care.
2012; 27: 743.e9–18.
34. Park JY, An JN, Jhee JH, Kim DK, Oh HJ, Kim S et al. Early initiation of continuous renal replacement
therapy improves survival of elderly patients with acute kidney injury: a multicenter prospective cohort
study. Crit Care. 2016; 20: 260. https://doi.org/10.1186/s13054-016-1437-8 PMID: 27526933
35. Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavensta¨dt H et al. Effect of Early vs
Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney
Negative fluid balance during continuous hemodiafiltration in acute kidney injury patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0175897 April 20, 2017 12 / 13
Injury: The ELAIN Randomized Clinical Trial. JAMA. 2016; 315: 2190–9. https://doi.org/10.1001/jama.
2016.5828 PMID: 27209269
36. Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B,Boulet E, Boyer A et al. Initiation strategies
for renal replacement therapy in the intensive care unit. N Engl J Med. 2016; 375: 122–33. https://doi.
org/10.1056/NEJMoa1603017 PMID: 27181456
37. Barbar SD, Binquet C, Monchi M, Bruyère R, Quenot JP. Impact on mortality of the timing of renal
replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study
(initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized
controlled trial. Trials. 2014; 15: 270. https://doi.org/10.1186/1745-6215-15-270 PMID: 24998258
38. Smith OM, Wald R, Adhikari NK, Pope K, Weir MA, Bagshaw SM. Canadian Critical Care Trials Group.
Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-
AKI): study protocol for a randomized controlled trial. Trials. 2013; 14: 320. https://doi.org/10.1186/
1745-6215-14-320 PMID: 24093950
39. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P et al. Effects of different doses in contin-
uous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial.
Lancet. 2000; 356: 26–30. https://doi.org/10.1016/S0140-6736(00)02430-2 PMID: 10892761
40. Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D et al. Intensity of renal
support in critically ill patients with acute kidney injury. N Engl J Med. 2008; 359: 7–20. https://doi.org/
10.1056/NEJMoa0802639 PMID: 18492867
41. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S et al. Intensity of continuous renal-replacement
therapy in critically ill patients. N Engl J Med. 2009; 361: 1627–1638. https://doi.org/10.1056/
NEJMoa0902413 PMID: 19846848
42. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al. Acute Kidney Injury Network.
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit
Care. 2007; 11: R31 https://doi.org/10.1186/cc5713 PMID: 17331245
43. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clini-
cal Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012; 2: 1–138
44. Oh HJ, Shin DH, Lee MJ, Ko KI, Kim CH, Koo HM et al. Urine output is associated with prognosis in
patients with acute kidney injury requiring continuous renal replacement therapy. J Crit Care. 2013; 28:
379–88. https://doi.org/10.1016/j.jcrc.2012.11.019 PMID: 23582311
45. Macedo E, Mehta RL. Preventing Acute Kidney Injury. Crit Care Clin. 2015; 31: 773–84. https://doi.org/
10.1016/j.ccc.2015.06.011 PMID: 26410144
46. de Mendonc¸a A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M et al. Acute renal failure in
the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000; 26: 915–
21. PMID: 10990106
47. Kheterpal S, Tremper KK, Heung M, Rosenberg AL, Englesbe M, Shanks AM et al. Development and
validation of an acute kidney injury risk index for patients undergoing general surgery: results from a
national data set. Anesthesiology. 2009; 110: 505–15.
Negative fluid balance during continuous hemodiafiltration in acute kidney injury patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0175897 April 20, 2017 13 / 13
